Tüüp : |
Ajaleht |
Interneti link : |
http://www.ijpc.com/Abstracts/Abstract.cfm?ABS=284 |
|
Uurimisrühmad : |
Houston - M.D.Anderson Cancer Center |
Autor : |
Zhang YP, Trissel LA, Fox JL. |
Pealkiri : |
Naratriptan hydrochloride in extemporaneously compounded oral suspensions. |
Publikatsioon : |
Int J Pharm Compound ; 4: 69-71. 2000 |
|
Tõendite tase : |
|
Füüsikaline stabiilsus : |
|
Keemiline püsivus : |
|
Muud meetodid : |
|
Kommentaarid : |
|
Ingredientide nimekiri
Naratriptan Hydrochloride
|
|
|
|
|
15 mg Amerge® |
OraPlus® / OraSweet® (1:1) |
>> 30 mL |
|
23°C |
|
7 |
|
|
|
|
|
|
15 mg Amerge® |
OraPlus® / OraSweet SF® (1:1) |
>> 30 mL |
|
23°C |
|
7 |
|
|
|
|
|
|
15 mg Amerge® |
OraPlus® / OraSweet® (1:1) |
>> 30 mL |
|
4°C |
|
90 |
|
|
|
|
|
|
15 mg Amerge® |
OraPlus® / OraSweet SF® (1:1) |
>> 30 mL |
|
4°C |
|
90 |
|
|
|
|
|